Hi Dabru,
Are you mixing LMAT up with 4C Medical?
We sold CC to LeMaitre Vascular not 4C. We supply Adapt treated tissue for 4C’s TMVR device called the Alta Valve. 4C Medical’s aim is to be bought out.
I suspect whoever buys AVR would also be interested in acquiring 4C medical if their Alta Valve continues to perform in their current EFS studies.
Of course their is a ton of future potential for AVR to supply a 3D version of DurMVR for TMVR whether that be with 4C or one for our own use. TMVR is however, a complicated beast that no one has really solved yet.
CEO presentation - one of the best I have seen., page-43
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.50 |
Change
0.100(0.65%) |
Mkt cap ! $327.6M | |||
| Open | High | Low | Value | Volume |
| $15.15 | $15.50 | $15.00 | $108.6K | 7.185K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 341 | $15.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.50 | 371 | 1 |
View Market Depth
| Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |